Lonza Clonetics HSeC-Human Sertoli cells

Monday, 11 October, 2010 | Supplied by: Lonza Australia Pty Ltd

Clonetics HSeC-Human Sertoli Cells are an asset to research involving male infertility and reproductive toxicology, xeno/allograft cotransplantation, immune suppression and many other applications.

Sertoli cells are highly specialised and essential for maintenance of testicular homeostasis and male reproductive viability.

QC characterisation of Sertoli cells includes testing for cellular proteins, seeding efficiency, doubling time and morphology and 70% confluence by day 12 in culture. Cells test positive for GATA-4 and Sox-9 at > 70% by flow cytometry.

Cells test negative for mycoplasma, bacteria, yeast and fungi. HIV-1 and Hepatitis B/C are not detected for all donors and/or cell lots.

A Certificate of Analysis is provided for each cell lot purchased.

Clonetics cells are guaranteed to perform as indicated when used with Clonetics Media and Reagents

Online: www.lonza.com
Phone: 03 9550 0883
Related Products

ORF Genetics ISOkine human recombinant leukaemia inhibitory factor (LIF)

ORF Genetics' ISOkine human recombinant LIF is a highly purified and endotoxin-free cytokine...

GeneTex recombinant antibodies

GeneTex offers over 300 recombinant antibodies for research into SARS-CoV-2, apoptosis, immune...

Solabia animal-free peptones

Six casein peptones, all of New Zealand origin, are available from Solabia, including tryptone,...

  • All content Copyright © 2021 Westwick-Farrow Pty Ltd